Buccutite FOL，马来酰亚胺 [FOLM]

产品基本信息

产品名称：Buccutite FOL，马来酰亚胺 [FOLM]

储存条件：-15℃避光防潮

保质期：12个月

产品物理化学光谱特性

外观：固体

分子量：523.63

溶剂：DMSO

产品介绍

Buccutite 交联技术提供了方便、有效的交联方法，以高共轭产率连接两个生物分子。该方法使用一对交联剂：Buccutite MTA 和 Buccutite FOL。 MTA 被添加到一个分子中，而 FOL 被添加到另一个分子中。通过在中性条件下混合 Molecule-1-Buccutite MTA 和 Molecule-2-Buccutite FOL 来引发交联反应。Buccutite FOL 马来酰亚胺 (FOLM) 的使用方式与广泛用于交联蛋白质的 SMCC 相同。 FOLM 的一端（通过马来酰亚胺）与还原抗体（通过 TCEP 或 DTT）中发现的半胱氨酸硫醇 (-SH) 反应，以产生 FOL 修饰的还原抗体。 Buccutite 交联反应在极其温和和中性的条件下发生，不需要任何催化剂，而 SMCC 交联需要高浓度的蛋白质。此外，SMCC 修饰的蛋白质极不稳定，通常会自我反应，因为蛋白质通常同时含有胺和硫醇基团，这会导致大量的同交联。Buccutite 交联反应在极其温和和中性的条件下发生，无需任何催化剂，它比SMCC更加稳定。

参考文献

N-Hydroxysuccinimide-Modified Ethynylphosphonamidates Enable the Synthesis of Configurationally Defined Protein Conjugates.
Authors: Kasper, Marc-André and Gerlach, Marcus and Schneider, Anselm F L and Groneberg, Christiane and Ochtrop, Philipp and Boldt, Stefanie and Schumacher, Dominik and Helma, Jonas and Leonhardt, Heinrich and Christmann, Mathias and Hackenberger, Christian P R
Journal: Chembiochem : a European journal of chemical biology (2020): 113-119

MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex.
Authors: Ku, Anthony and Chan, Conrad and Aghevlian, Sadaf and Cai, Zhongli and Cescon, David and Bratman, Scott V and Ailles, Laurie and Hedley, David W and Reilly, Raymond M
Journal: Molecular pharmaceutics (2019): 3559-3568

2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation.
Authors: Dovgan, Igor and Kolodych, Sergii and Koniev, Oleksandr and Wagner, Alain
Journal: Scientific reports (2016): 30835

Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Authors: Ponte, Jose F and Sun, Xiuxia and Yoder, Nicholas C and Fishkin, Nathan and Laleau, Rassol and Coccia, Jennifer and Lanieri, Leanne and Bogalhas, Megan and Wang, Lintao and Wilhelm, Sharon and Widdison, Wayne and Pinkas, Jan and Keating, Thomas A and Chari, Ravi and Erickson, Hans K and Lambert, John M
Journal: Bioconjugate chemistry (2016): 1588-98

Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
Authors: Ehrlich, George K and Michel, Hanspeter and Truitt, Theresa and Riboulet, William and Pop-Damkov, Petar and Goelzer, Petra and Hainzl, Dominik and Qureshi, Farooq and Lueckel, Barbara and Danho, Waleed and Conde-Knape, Karin and Konkar, Anish
Journal: Bioconjugate chemistry (2013): 2015-24

Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation.
Authors: Lau, Shannen and Graham, Bim and Cao, Nga and Boyd, Ben J and Pouton, Colin W and White, Paul J
Journal: Molecular pharmaceutics (2012): 71-80

Protein labeling with the labeling precursor [(18)F]SiFA-SH for positron emission tomography.
Authors: Wängler, Björn and Kostikov, Alexey P and Niedermoser, Sabrina and Chin, Joshua and Orchowski, Katy and Schirrmacher, Esther and Iovkova-Berends, Liuba and Jurkschat, Klaus and Wängler, Carmen and Schirrmacher, Ralf
Journal: Nature protocols (2012): 1964-9

Commercially Supplied Amine-Modified siRNAs May Require Ultrafiltration prior to Conjugation with Amine-Reactive Compounds.
Authors: Lau, Shannen and Graham, Bim and Boyd, Ben J and Pouton, Colin W and White, Paul J
Journal: Journal of nucleic acids (2011): 154609

Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.
Authors: Christie, R James and Anderson, Diana J and Grainger, David W
Journal: Bioconjugate chemistry (2010): 1779-87

Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin.
Authors: Bhandari, Krishna Hari and Newa, Madhuri and Uludag, Hasan and Doschak, Michael R
Journal: International journal of pharmaceutics (2010): 26-34